REQUEST A DEMO
Total
USD $0.00
Search more companies

Hlb Therapeutics Co., Ltd. (South Korea)

Main Activities: Software Publishers
Full name: Hlb Therapeutics Co., Ltd. Profile Updated: January 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Hlb Therapeutics Co., Ltd. is an enterprise in South Korea, with the main office in Seongnam. It operates in the Software Publishers sector. The enterprise was incorporated on June 07, 2000. It currently has a total number of 95 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 21.61% in Q3C2025. Its’ total assets recorded a growth of 11.39%. The net profit margin of Hlb Therapeutics Co., Ltd. increased by 43.84% in 2025.

Headquarters
22F Parkview Tower 6, Jeongja-Dong, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi; Postal Code: 463-811

Contact Details: Purchase the Hlb Therapeutics Co., Ltd. report to view the information.

Website: http://www.digitalaria.com

Basic Information
Total Employees:
Purchase the Hlb Therapeutics Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Hlb Therapeutics Co., Ltd. report to view the information.
Registered Capital:
Purchase the Hlb Therapeutics Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Hlb Therapeutics Co., Ltd. report to view the information.
Incorporation Date:
June 07, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
10.3%
Subsidiaries
(주)지트리파마슈티컬
100%
Oblato Inc.
100%
보태전자(천진)유한공사
100%
Company Performance
Financial values in the chart are available after Hlb Therapeutics Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
21.61%
Total Operating Revenue
15.75%
Operating Profit
24.74%
EBITDA
-241%
Net Profit/Loss for the Period
59.68%
Total Assets
11.39%
Total Equity
0.68%
Operating Profit Margin
13.72%
Net Profit Margin
43.84%
Return on Equity (ROE)
8.97%
Debt / Equity
1444%
Quick Ratio
-1970.57%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?